ScoreChip research consortium for improving medical diagnostics with the participation of INVIGATE GmbH

Since September 1st, 2024, INVIGATE GmbH has been conducting research together with the Thuringian Innovation Center for Medical Technology Solutions (ThIMEDOP), Mildendo GmbH, and the Institute for Microelectronics and Mechatronic Systems (Ilmenau) on a compact, application-open sensor chip technology. The envisaged technology enables the simultaneous detection of multiple biomarker signatures to obtain biomedically relevant information in a short time. The unique design of the biochemical probes involved, combined with a powerful microfluidic chip format and an innovative luminescence reader, aims to create new options for point-of-care (PoC) diagnostics.

With the proposed solution the ScoreChip consortium strives to address the growing challenges in clinical care faced which are simultaneously faced with high cost pressures.

INVIGATE GmbH is committed to the development of long-lasting biological and biochemical probes for so-called rapid assays that are capable to run within the envisaged sensor chip format.

The project is funded with approximately € 573,000 by the Thüringer Aufbaubank, co-financed by the European Union, for a duration of three years.